2018
DOI: 10.1016/j.neuroscience.2018.10.015
|View full text |Cite
|
Sign up to set email alerts
|

Mu-opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat

Abstract: Stimulation of the mu-opioid receptor (MOR) on nociceptors with fentanyl can produce hyperalgesia (opioid-induced hyperalgesia, OIH) and hyperalgesic priming, a model of transition to chronic pain. We investigated if local and systemic administration of biased MOR agonists (PZM21 and TRV130), which preferentially activate G-protein over β-arrestin translocation, and have been reported to minimize some opioid side effects, also produces OIH and priming. Injected intradermally (100 ng), both biased agonists indu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 32 publications
(32 citation statements)
references
References 58 publications
0
32
0
Order By: Relevance
“…It has been well documented that the peripheral activation of Gi-coupled receptors in DRG neurons may induce hyperalgesia and promote mechanical pain (Araldi et al, 2016(Araldi et al, , 2018Yudin and Rohacs, 2018). Intradermal hind paw injection of the migraine drug sumatriptan for example evoked both an acute hyperalgesia 30 minutes after its injection, and hyperalgesic priming, potentiating the effect of PGE2, an effect that developed several days after the injection of the drug (Araldi et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been well documented that the peripheral activation of Gi-coupled receptors in DRG neurons may induce hyperalgesia and promote mechanical pain (Araldi et al, 2016(Araldi et al, , 2018Yudin and Rohacs, 2018). Intradermal hind paw injection of the migraine drug sumatriptan for example evoked both an acute hyperalgesia 30 minutes after its injection, and hyperalgesic priming, potentiating the effect of PGE2, an effect that developed several days after the injection of the drug (Araldi et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…Many different Gi-coupled receptors, such as GABAB and opioid receptors are expressed in DRG neurons; their activation generally reduces excitability, and exert analgesic effects (Yudin and Rohacs, 2018). Activation of many Gi-coupled receptors however was shown to induce mechanical hypersensitivity, the mechanism of which is not understood (Araldi et al, 2016(Araldi et al, , 2018Yudin and Rohacs, 2018) Here we found that activation of Gi-coupled receptors potentiated native Piezo2-mediated currents in DRG neurons and heterologous expressed Piezo2 channels in HEK293 cells without affecting the number of channels at the plasma membrane. Surprisingly, the currents of the closely related Piezo1 channels were inhibited after activation of Gi-coupled receptors in HEK293 cells.…”
Section: Introductionmentioning
confidence: 99%
“…[2][3][4] However, recent investigations of these biased agonists indicate that side effects, including constipation and respiratory depression, may still be retained. [5][6][7][8] Thus, there is a need for greater understanding of how opioid receptor regulation and signaling underlie the control of physiological processes, including GI motility.…”
Section: See Editorial On Page 553mentioning
confidence: 99%
“…We have recently shown that depending on the opioid used, and its dose and route of administration, opioids are capable of inducing acute hyperalgesia, even after a single administration (Araldi et al, 2015(Araldi et al, , 2018b(Araldi et al, ,c, 2019Ferrari et al, 2019). In particular, clinically used -opioid receptor (MOR) agonists, fentanyl (Araldi et al, 2018c) and morphine (Araldi et al, 2019;Ferrari et al, 2019), as well as the highly selective MOR agonist, DAMGO (Araldi et al, 2015(Araldi et al, , 2017(Araldi et al, , 2018a, produce OIH and hyperalgesic priming, a form of nociceptor neuroplasticity characterized by a persistent increase in responsivity of nociceptors to proalgesic mediators (Ferrari et al, 2010;Joseph and Levine, 2010b;Alvarez et al, 2014;Araldi et al, 2015;Khomula et al, 2017).…”
Section: Introductionmentioning
confidence: 99%